PL368727A1 - 17alfa-hydroksy-14beta-steroidy o działaniu hormonalnym - Google Patents

17alfa-hydroksy-14beta-steroidy o działaniu hormonalnym

Info

Publication number
PL368727A1
PL368727A1 PL02368727A PL36872702A PL368727A1 PL 368727 A1 PL368727 A1 PL 368727A1 PL 02368727 A PL02368727 A PL 02368727A PL 36872702 A PL36872702 A PL 36872702A PL 368727 A1 PL368727 A1 PL 368727A1
Authority
PL
Poland
Prior art keywords
14beta
17alpha
steroids
hydroxy
hormonal effect
Prior art date
Application number
PL02368727A
Other languages
English (en)
Other versions
PL207493B1 (pl
Inventor
Der Louw Jaap Van
Dirk Leysen
Gooijer Marcel Evert De
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL368727(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of PL368727A1 publication Critical patent/PL368727A1/pl
Publication of PL207493B1 publication Critical patent/PL207493B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL368727A 2001-09-12 2002-09-06 17α-hydroksy-14β-steroidy i ich zastosowanie PL207493B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12

Publications (2)

Publication Number Publication Date
PL368727A1 true PL368727A1 (pl) 2005-04-04
PL207493B1 PL207493B1 (pl) 2010-12-31

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
PL368727A PL207493B1 (pl) 2001-09-12 2002-09-06 17α-hydroksy-14β-steroidy i ich zastosowanie

Country Status (28)

Country Link
US (1) US7169769B2 (pl)
EP (1) EP1427748B1 (pl)
JP (1) JP4471653B2 (pl)
KR (1) KR100940054B1 (pl)
CN (1) CN1257913C (pl)
AR (1) AR036462A1 (pl)
AT (1) ATE395352T1 (pl)
AU (1) AU2002339536B2 (pl)
BR (1) BR0212409A (pl)
CA (1) CA2505575C (pl)
CY (1) CY1108152T1 (pl)
DE (1) DE60226623D1 (pl)
DK (1) DK1427748T3 (pl)
EC (1) ECSP045012A (pl)
ES (1) ES2305306T3 (pl)
HR (1) HRP20040193A2 (pl)
HU (1) HUP0402139A3 (pl)
IL (2) IL160451A0 (pl)
IS (1) IS2555B (pl)
MX (1) MXPA04002418A (pl)
NO (1) NO326624B1 (pl)
NZ (1) NZ531487A (pl)
PL (1) PL207493B1 (pl)
PT (1) PT1427748E (pl)
RU (1) RU2294332C2 (pl)
TW (1) TWI221154B (pl)
WO (1) WO2003022864A1 (pl)
ZA (1) ZA200401992B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
ATE228143T1 (de) 1999-03-08 2002-12-15 Akzo Nobel Nv 14.beta.,17-alpha-hydroxymethylandrostan derivate als androgene
WO2001064227A2 (en) * 2000-02-29 2001-09-07 The National University Of Singapore Androgenic activity of eucommia ulmoides extracts
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
HK1063637A1 (en) 2005-01-07
NZ531487A (en) 2005-08-26
EP1427748B1 (en) 2008-05-14
PT1427748E (pt) 2008-08-27
PL207493B1 (pl) 2010-12-31
IS2555B (is) 2009-10-15
RU2004110934A (ru) 2005-08-20
JP2005505566A (ja) 2005-02-24
ATE395352T1 (de) 2008-05-15
NO20041010L (no) 2004-03-10
HUP0402139A2 (hu) 2005-02-28
HRP20040193A2 (en) 2004-08-31
EP1427748A1 (en) 2004-06-16
AU2002339536B2 (en) 2008-04-24
CN1257913C (zh) 2006-05-31
CA2505575A1 (en) 2003-03-20
MXPA04002418A (es) 2004-07-30
CN1553917A (zh) 2004-12-08
IL160451A (en) 2009-11-18
IL160451A0 (en) 2004-07-25
WO2003022864A1 (en) 2003-03-20
US7169769B2 (en) 2007-01-30
HUP0402139A3 (en) 2012-12-28
TWI221154B (en) 2004-09-21
KR100940054B1 (ko) 2010-02-04
CY1108152T1 (el) 2014-02-12
AR036462A1 (es) 2004-09-08
BR0212409A (pt) 2004-08-03
DE60226623D1 (de) 2008-06-26
CA2505575C (en) 2010-01-26
KR20040039346A (ko) 2004-05-10
DK1427748T3 (da) 2008-09-08
JP4471653B2 (ja) 2010-06-02
ZA200401992B (en) 2005-04-21
ECSP045012A (es) 2004-09-27
IS7165A (is) 2004-02-26
US20040259849A1 (en) 2004-12-23
ES2305306T3 (es) 2008-11-01
RU2294332C2 (ru) 2007-02-27
NO326624B1 (no) 2009-01-19

Similar Documents

Publication Publication Date Title
DE60217162D1 (en) Tetrafluorethen-perfluorbutylethen-copolymer
DE60217478D1 (en) Sychrongleichrichter
DE60231477D1 (en) Imidazolderivate
DE60141362D1 (en) Ösophagus-stoma-knopf
DE50202633D1 (en) Ophthalmoskop
DE60218514D1 (en) Polyolefin-kunststoffrohre
EP1417203A4 (en) S-6-HYDROXY-BUSPIRONE
GB2392916B (en) Deicing
DE60226167D1 (en) Computersystem-e/a-knoten
DE50214962D1 (en) Heterocyclylarylsulfonamide
DE50201028D1 (en) Diarylgelbpigmentpraeparationen
AU2001100134A4 (en) Enviro-trap
PT1427748E (pt) 17alfa-hidroxi-14beta-esteróides com efeito hormonal
GB0117479D0 (en) Jetters
GB0118576D0 (en) Quadrail supertrain
AU2288P (en) Prime322 xTriticosecale
CA93126S (en) Titlt-latch
CA93646S (en) Fauteuil
GB0102149D0 (en) Plant - remover
GB0119140D0 (en) Wow-wow
GB0119907D0 (en) E-locator
GB0110509D0 (en) Klinette
GB0122584D0 (en) Leadtidy
GB0118810D0 (en) Demshute
GB0112490D0 (en) Reactor-vision-3

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120906